
Peter Alfred Lewitt MD M.Med.Sc.
Movement Disorder, Neurodegenerative
Professor of Neurology at Wayne State University School of Medicine and Sastry Foundation Endowed Chair in Neurology, Detroit, Michigan. Movement Disorder neurologist at Henry Ford Hospital, West Bloomfield, Michigan
Join to View Full Profile
4201 St.Antoine 8-DDetroit, MI 48202
Phone+1 248-412-3409
Dr. Lewitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of HealthFellowship, 1980 - 1983
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
- Philadelphia General HospitalInternship, Internal Medicine, 1975 - 1976
- Brown UniversityM.Med.Sc., Biochemical Pharmacology, 1971 - 1975
- The Warren Alpert Medical School of Brown UniversityClass of 1975
- Brown UniversityAB, 1968 - 1972
Certifications & Licensure
- MI State Medical License 1983 - 2027
- MD State Medical License 1982 - 1984
- PA State Medical License 1976 - 1978
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease Start of enrollment: 2012 Apr 01
- Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease Start of enrollment: 2015 Mar 01
Publications & Presentations
PubMed
- Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.Stuart H Isaacson, Alberto J Espay, Rajesh Pahwa, Pinky Agarwal, Holly A Shill
Journal of Parkinson's Disease. 2025-03-01 - The effect of AKT inhibition in α-synuclein-dependent neurodegeneration.Bedri Ranxhi, Zoya R Bangash, Zachary M Chbihi, Sokol V Todi, Peter A LeWitt
Frontiers in Molecular Neuroscience. 2025-01-01 - 1 citationsAnticholinergic drugs for parkinsonism and other movement disorders.Peter A LeWitt, Luke Hong, Mark S Moehle
Journal of Neural Transmission. 2024-12-01
Journal Articles
- Dopamine Metabolite Biomarkers and Testing for Disease Modification in Parkinson DiseasePeter Lewitt, MD, JAMA Neurology
- Double-blind Study of an Actively-transported Levodopa Prodrug, XP21279, in Parkinson DiseaseLeWitt PA, Huff FJ, Hauser R, Chen D, Lissin D, Cundy K, Mov Disord, 1/1/2014
- Test-retest Reliability of an Objective PD Monitoring SystemHeldman DA, Espay AJ, LeWitt PA, Giuffrida JP, Parkinsonism Relat Disord, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Accordion Pill Carbidopa/Levodopa (AP CD/LD) for Treatment of Advanced Parkinson's Disease (PD).LeWitt PA, Giladi N, Gurevich T, Shabtai H, Djaldetti R, Roizen N, Hassin-Baer S, Cohen O, Yahalom G, Schlesinger I, Nassar M, Milo R, Anca M, Farkas P, Lamp Y, Navon ..., Mov Disord, 1/1/2014
- Incisionless Thalamotomy for Essential Tremor by MR-guided Focused Ultrasound -randomized, Sham-controlled TrialOndo W, LeWitt P, Elias WJ, Mov Disord, 1/1/2014
- A Novel Mutation Resulting in a Mild Phenotype of Spinocerebellar Ataxia 13Herrema H, Sidiropoulos C, LeWitt P, Mov Disord, 1/1/2014
- Join now to see all
Authored Content
- Dopamine Metabolite Biomarkers and Testing for Disease Modification in Parkinson DiseaseJune 2020
Grant Support
- Southeastern Michigan Parkinson'S Disease ProgramNational Institute Of Neurological Disorders And Stroke2002–2006
- Nocardia: A Novel Environmental Agent For Parkinsonism?National Institute Of Environmental Health Sciences2001–2003
- Parkinson Disease Pathophysiology--Csf MarkersNational Institute Of Neurological Disorders And Stroke1990–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: